The Future of B-cell Activating Factor Antagonists in the Treatment of Systemic Lupus Erythematosus

B Cell ◽

Lupus Erythematosus ◽

Systemic Lupus ◽

The Future

Faculty Opinions recommendation of Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160897.627349 ◽

2009 ◽

Author(s):

Sarah Gaffen ◽

Allen Ho

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Retraction Note: Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Nature Immunology ◽

10.1038/ni0914-894a ◽

2014 ◽

Vol 15 (9) ◽

pp. 894-894

Author(s):

Agnès Doreau ◽

Alexandre Belot ◽

Jérémy Bastid ◽

Benjamin Riche ◽

Marie-Claude Trescol-Biemont ◽

...

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Nature Immunology ◽

10.1038/ni.1741 ◽

2009 ◽

Vol 10 (7) ◽

pp. 778-785 ◽

Cited By ~ 327

Author(s):

Agnès Doreau ◽

Alexandre Belot ◽

Jérémy Bastid ◽

Benjamin Riche ◽

Marie-Claude Trescol-Biemont ◽

...

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

AB0554 Expression of Serum B Cell Activating Factor from the Tumour Necrosis Factor Family (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Systemic Lupus Erythematosus: Relationship with Disease Activity

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.3582 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 989.1-989

Author(s):

T. Panafidina ◽

M. Sokhova ◽

Z. Verizhnikova ◽

A. Novikov ◽

E. Alexandrova ◽

...

Keyword(s):

Disease Activity ◽

B Cell ◽

Tumour Necrosis Factor ◽

Lupus Erythematosus ◽

Tumour Necrosis ◽

Systemic Lupus ◽

Necrosis Factor

Faculty Opinions recommendation of Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160897.623684 ◽

2009 ◽

Author(s):

Kazuhiko Yamamoto ◽

Akiko Okamoto

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Cell Biology ◽

Interleukin 17 ◽

Systemic Lupus ◽

B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)

Autoimmunity Reviews ◽

10.1016/j.autrev.2020.102736 ◽

2020 ◽

pp. 102736

Author(s):

Tamara Möckel ◽

Fabio Basta ◽

Julia Weinmann-Menke ◽

Andreas Schwarting

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Structure Functions ◽

Clinical Implications ◽

Systemic Lupus ◽

AB0621 Expression of Serum B Cell Activating Factor from the Tumor Necrosis Factor Family (BAFF) and of Proliferation-Inducing Ligand (APRIL) in Patients with Untreated Systemic Lupus Erythematosus

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.5107 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 1107.1-1107

Author(s):

T. Panafidina ◽

M. Sokhova ◽

T. Popkova ◽

Z. Verizhnikova ◽

A. Novikov ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

B Cell ◽

Lupus Erythematosus ◽

Tumor Necrosis ◽

Systemic Lupus ◽

Tumor Necrosis Factor Family ◽

Necrosis Factor

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjogren's syndrome and systemic lupus erythematosus

Annals of the Rheumatic Diseases ◽

10.1136/ard.2006.065656 ◽

2007 ◽

Vol 66 (6) ◽

pp. 790-797 ◽

Cited By ~ 54

Author(s):

J. Sellam ◽

C. Miceli-Richard ◽

J.-E. Gottenberg ◽

M. Ittah ◽

F. Lavie ◽

...

Keyword(s):

Disease Activity ◽

B Cell ◽

Lupus Erythematosus ◽

Primary Sjögren’S Syndrome ◽

Receptor Expression ◽

Systemic Lupus ◽

Primary Sjogren’S Syndrome ◽

Peripheral Lymphocytes ◽

Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production

Rheumatology ◽

10.1093/rheumatology/kem097 ◽

2007 ◽

Vol 46 (7) ◽

pp. 1083-1086 ◽

Cited By ~ 49

Author(s):

S. Morimoto ◽

S. Nakano ◽

T. Watanabe ◽

Y. Tamayama ◽

A. Mitsuo ◽

...

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Tumour Necrosis ◽

Systemic Lupus ◽

Autoantibody Production ◽

Pathogenic Autoantibody ◽

Necrosis Factor

Correlation of B-cell-activating factor levels and diseases activity in systemic lupus erythematosus patients

Indian Journal of Rheumatology ◽

10.4103/injr.injr_122_20 ◽

2020 ◽

Vol 0 (0) ◽

pp. 0

Author(s):

Laniyati Hamijoyo ◽

RiaYolanda Vitri ◽

RachmatGunadi Wachjudi ◽

NadiaGita Ghassani

Keyword(s):

B Cell ◽

Lupus Erythematosus ◽

Systemic Lupus ◽